<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02948179</url>
  </required_header>
  <id_info>
    <org_study_id>CZKIPLA-ADPKD-003</org_study_id>
    <nct_id>NCT02948179</nct_id>
  </id_info>
  <brief_title>Using Preimplantation Genetic Diagnosis in Autosomal Dominant Polycystic Kidney Disease Patients: a Multicenter Clinical Trial</brief_title>
  <acronym>ESPERANCE</acronym>
  <official_title>Efficacy and Safety of Preimplantation Genetic Diagnosis in Blocking Pathogenic Gene Inheritance for Autosomal Dominant Polycystic Kidney Disease: a Multicenter Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Changlin Mei</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The First Affiliated Hospital of Anhui Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The First Affiliated Hospital with Nanjing Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shandong Provincial Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Tang-Du Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shengjing Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Second Xiangya Hospital of Central South University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Reproductive &amp; Genetic Hospital of CITIC-Xiangya</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Peking University Third Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Navy General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The First Affiliated Hospital of Soochow University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sir Run Run Shaw Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fuzhou General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The First Affiliated Hospital of Zhengzhou University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Wuhan TongJi Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Wuhan Union Hospital, China</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Renmin Hospital of Wuhan University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Xiangya Hospital of Central South University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>First Affiliated Hospital, Sun Yat-Sen University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Southwest Hospital, China</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>LanZhou University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shaanxi Provincial People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>West China Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>West China Second University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sichuan Provincial People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hebei Medical University Third Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hebei Province Center for Reproductive Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Second Hospital of Hebei Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital for Reproductive Medicine Affiliated to Shandong University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Shanghai Changzheng Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Autosomal dominant polycystic kidney disease (ADPKD) is the most common monogenic hereditary
      kidney disease in humans. ADPKD may affect all the generations of the ADPKD family and the
      probability of ADPKD is 50% in the second generation for each gender. It has been confirmed
      that PKD1 and PKD2 are two pathogenic genes of ADPKD. Nowadays, the investigators have
      established an effective gene detection technology platform for PKD1/2 gene with long
      fragment PCR and next generation sequencing. First, the investigators performed genetic
      testing in patients with clinically diagnosed ADPKD and strong fertility desire, but afraid
      of hereditary risk. Using Preimplantation genetic diagnosis, including multiple annealing and
      looping-based amplification cycles amplification technique, the investigators successfully
      screened out healthy embryos by In Vitro Fertilization. Then the investigators transplanted
      embryos returned to the parent. When the baby is born, using umbilical cord blood gene
      detection, the investigators confirmed that the neonates do not inherit genetic defects form
      parents. The investigators have succeeded in one couple. The investigators design a
      multicenter clinical trial to confirm those procedures efficacy and safety.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 2, 2016</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Healthy baby Rate without pathogenic gene inheritance</measure>
    <time_frame>through study completion, an average of 2 year</time_frame>
    <description>The investigators will do umbilical cord blood gene detection for the baby to confirm with or without pathogenic gene inheritance. The investigators will compare two groups of healthy newborns rate.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Success rate in pretest of preimplantation genetic diagnosis</measure>
    <time_frame>through study completion, an average of 2 year</time_frame>
    <description>Using couples blood to do pretest of preimplantation genetic diagnosis in Peripheral blood mononuclear lymphocyte.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Technical failure rate of preimplantation genetic diagnosis.</measure>
    <time_frame>Amniotic fluid puncture test (pregnancy 16 to 19 weeks ) and Birth day</time_frame>
    <description>The rate of amniotic fluid puncture test or umbilical cord blood gene detection confirm the offspring containing pathogenic gene mutation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oocyte retrieval rate</measure>
    <time_frame>through study completion, an average of 2 years</time_frame>
    <description>The proportion of good eggs obtained after ovulation induction</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Good quality embryo rate</measure>
    <time_frame>through study completion, an average of 2 years</time_frame>
    <description>The well-developed blastocyst ratio obtained after intracytoplasmic sperm injection</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pregnancy rate</measure>
    <time_frame>Four weeks after embryo transplantation</time_frame>
    <description>Successful pregnancy rate of transplanted embryo</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Take home baby rate</measure>
    <time_frame>Two week after neonatus birth day</time_frame>
    <description>Healthy newborn birth rate in preimplantation genetic diagnosis group</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The total kidney volume change rate</measure>
    <time_frame>From enroll to postpartum 6 months</time_frame>
    <description>The investigators do twice kidney MRI scan for calculating total kidney volume change rate between enroll and postpartum 6 months.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The estimated glomerular filtration rate change</measure>
    <time_frame>From enroll to postpartum 6 months</time_frame>
    <description>The investigators do twice serum creatinine test between enroll and postpartum 6 months, then using CKD-EPI formula to calculate eGFR.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>The incidence of ovarian hyperstimulation syndrome</measure>
    <time_frame>through study completion, an average of 2 years</time_frame>
    <description>the incidence of ovarian hyperstimulation syndrome</description>
  </other_outcome>
  <other_outcome>
    <measure>The incidence of organ injuries</measure>
    <time_frame>through study completion, an average of 2 years</time_frame>
    <description>the incidence of organ injuries</description>
  </other_outcome>
  <other_outcome>
    <measure>The incidence of infection</measure>
    <time_frame>through study completion, an average of 2 years</time_frame>
    <description>the incidence of infection</description>
  </other_outcome>
  <other_outcome>
    <measure>The incidence of abortion rate</measure>
    <time_frame>through study completion, an average of 2 years</time_frame>
    <description>the incidence of abortion rate</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Polycystic Kidney, Type 1 Autosomal Dominant Disease</condition>
  <arm_group>
    <arm_group_label>Preimplantation genetic diagnosis group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>ADPKD patients will complete the whole process of preimplantation genetic diagnosis with healthy baby without pathogenic gene inheritance.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Natural pregnancy group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>ADPKD patients, pathogenic mutations in PKD1, have natural pregnancy without preimplantation genetic diagnosis.The investigators will perform genetic tests on the blood or umbilical cord blood of infants born between January 2014 and June 2020.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Preimplantation Genetic Diagnosis</intervention_name>
    <description>Using Preimplantation genetic diagnosis, including multiple annealing and looping-based amplification cycles amplification technique, the investigators have had screened out healthy embryos by In Vitro Fertilization. Then the investigators transplanted embryos returned to the parent. Finally, participants will have healthy baby without pathogenic gene inheritance.</description>
    <arm_group_label>Preimplantation genetic diagnosis group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Only one ADPKD patient in one couple without gender limitation

          -  Wife has age limitation from 20 years to 35 years

          -  ADPKD ADPKD diagnosis with or without family history

          -  Find out specific pathogenic mutations in the PKD1 gene with at least one of the
             following: one of family patients done kidney transplantation or renal replacement
             therapy before 58 years old; one of family patients died of complications before 55
             years old; the patient with total kidney volume more than 650ml; the patient with
             total kidney volume increase rate more than 6% every year; the patient's PKD1 mutation
             belongs to truncated gene mutation.

          -  Both husband and wife have assisted reproductive conditions and will

          -  Pregnancy compliance with Chinese laws

          -  Signed informed consent

        Exclusion Criteria:

          -  Active pathogenic microorganism infection, such as hepatitis B or C, HIV, pulmonary
             tuberculosis, giant cell virus, fungi or other contraindications for preimplantation
             genetic diagnosis and so on

          -  Any one of the couple has used any drugs which may lead to abnormal reproductive
             system function, reproductive cell abnormalities, pregnancy risk increases in the past
             3 months, or has history of drug abuse

          -  Any one of the couple has malignancy

          -  The wife has uncontrolled hypertension or refractory hypertension

          -  The wife has diabetes mellitus

          -  The wife has albuminuria

          -  The wife has autoimmune disease

          -  The wife has other disorders or functional abnormalities, such as liver or renal
             dysfunction, which may be aggravated by pregnancy or assisted reproduction

          -  Allergy to drugs or related products which cannot avoid in our study

          -  Participating in other clinical studies in last 3 months

          -  Participants cannot follow the study program

          -  Other conditions that the researchers considered unsuitable for participation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>changlin Mei, Master</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institute of Nephrology, Changzheng Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>wen Li, doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Center of Reproductive Medicine, Changzheng Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yiyi Ma, doctor</last_name>
    <phone>+8613661679863</phone>
    <email>dukemm@126.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Bo Yang, doctor</last_name>
    <phone>+8613585694444</phone>
    <email>sternothyroid@live.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Anhui Medical University</name>
      <address>
        <city>Hefei</city>
        <state>Anhui</state>
        <zip>230000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>dawei Chen</last_name>
      <phone>+8615056057296</phone>
    </contact>
    <investigator>
      <last_name>yunxia Cao, doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>yonggui Wu, doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Navy General Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tao Wu</last_name>
      <phone>+8618801498842</phone>
      <email>1286060648@qq.com</email>
    </contact>
    <investigator>
      <last_name>Wei Shang</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mingxu Li</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Peking University Third Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Danxia Zheng, Doctor</last_name>
      <phone>+8615611908597</phone>
      <email>dxzheng@sina.com</email>
    </contact>
    <investigator>
      <last_name>Yue Wang, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ping Liu, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Southwest Hospital</name>
      <address>
        <city>Chongqing</city>
        <state>Chongqing</state>
        <zip>400000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yuxiu Sheng</last_name>
      <phone>+8615902361848</phone>
      <email>saidycloud@163.com</email>
    </contact>
    <investigator>
      <last_name>Wei He</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hongwen Zhao</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fuzhou General Hospital</name>
      <address>
        <city>Fuzhou</city>
        <state>Fujian</state>
        <zip>350000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yongze Zhuang</last_name>
      <phone>+8613609559583</phone>
      <email>zhuangyongze@126.com</email>
    </contact>
    <investigator>
      <last_name>Yongze Zhuang</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yun Liu</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The First Hospital of Lanzhou University</name>
      <address>
        <city>Lanzhou</city>
        <state>Gansu</state>
        <zip>730000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Tianxi Liu</last_name>
      <phone>+8613919060937</phone>
      <email>liutianxi_2018@126.com</email>
    </contact>
    <investigator>
      <last_name>Tianxi Liu</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Xuehong Zhang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sun Yat-sen Memorial Hospital of Sun Yat-sen University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Lingyan Zheng</last_name>
      <phone>+8618680245078‬</phone>
      <email>lyzheng6@163.com</email>
    </contact>
    <investigator>
      <last_name>Anping Xu</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Qingxue Zhang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Sun Yat-sen University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hebei Province Center for Reproductive Medicine</name>
      <address>
        <city>Shijiazhuang</city>
        <state>Hebei</state>
        <zip>050000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Huixia Zhang</last_name>
      <phone>+86 0311 87812345</phone>
      <email>jjzhang369@126.com</email>
    </contact>
    <investigator>
      <last_name>Huixia Zhang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Second Hospital of Hebei Medical University</name>
      <address>
        <city>Shijiazhuang</city>
        <state>Hebei</state>
        <zip>050000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wei Wang</last_name>
      <phone>+8613832177339</phone>
      <email>wangwei_ivf@163.com</email>
    </contact>
    <investigator>
      <last_name>Guimin Hao</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Third Hospital of Hebei Medical University</name>
      <address>
        <city>Shijiazhuang</city>
        <state>Hebei</state>
        <zip>050000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Tao Zhang</last_name>
      <phone>+8618533112281</phone>
      <email>lann78@126.com</email>
    </contact>
    <investigator>
      <last_name>Ying Li</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Zhengzhou University</name>
      <address>
        <city>Zhengzhou</city>
        <state>Henan</state>
        <zip>450000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jiawei Xu</last_name>
      <phone>+8618695822866</phone>
      <email>jiawxu@foxmail.com</email>
    </contact>
    <investigator>
      <last_name>Zhangsuo Liu</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jiawei Xu</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Renmin Hospital of Wuhan University</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <zip>430000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Guohua Ding</last_name>
      <phone>+8613554023015</phone>
      <email>ghxding@qq.com</email>
    </contact>
    <investigator>
      <last_name>Jing Yang</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Guohua Ding</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Wuhan Tongji Hospital</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <zip>430000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Junhua Li</last_name>
      <phone>+8615102795258</phone>
      <email>lijunhua333@163.com</email>
    </contact>
    <investigator>
      <last_name>Gang Xu</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lei Jin</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Wuhan Union Hospital</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <zip>430000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jing Xiong</last_name>
      <phone>+8618963953980</phone>
      <email>xiongjing76718@126.com</email>
    </contact>
    <investigator>
      <last_name>Ying Gao</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Chun Zhang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Reproductive &amp; Genetic Hospital of CITIC-Xiangya</name>
      <address>
        <city>Changsha</city>
        <state>Hunan</state>
        <zip>410000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>juan Du</last_name>
      <phone>+8618684675296</phone>
    </contact>
    <investigator>
      <last_name>ge Lin, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Second Xiangya Hospital of Central South University</name>
      <address>
        <city>Changsha</city>
        <state>Hunan</state>
        <zip>410000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>xun zhou</last_name>
      <phone>+8613755026744</phone>
    </contact>
    <investigator>
      <last_name>hong Liu, doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Xiangya Hospital of Central South University</name>
      <address>
        <city>Changsha</city>
        <state>Hunan</state>
        <zip>410000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rong Tang</last_name>
      <phone>+8615274813056</phone>
      <email>38910847@qq.com</email>
    </contact>
    <investigator>
      <last_name>Xiangcheng Xiao</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yanping Li</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Miao Zhang</last_name>
      <phone>+8613951796299</phone>
      <email>zmslp@medmail.com.cn</email>
    </contact>
    <investigator>
      <last_name>Haixiang Sun</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Miao Zhang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital with Nanjing Medical University</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>jiandong Shen, doctor</last_name>
      <email>jiandongsh@163.com</email>
    </contact>
    <investigator>
      <last_name>changying Xing, doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>jiandong Shen, doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Soochow University</name>
      <address>
        <city>Suzhou</city>
        <state>Jiangsu</state>
        <zip>215000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yanyan Zhuang</last_name>
      <phone>+8615995541907</phone>
      <email>byy0504@163.com</email>
    </contact>
    <investigator>
      <last_name>Caiping Mao</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Guoyuan Lu</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shengjing Hospital</name>
      <address>
        <city>Shenyang</city>
        <state>Liaoning</state>
        <zip>110000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>jiao Jiao</last_name>
      <phone>+8618940252509</phone>
      <email>13889284796@163.com</email>
    </contact>
    <investigator>
      <last_name>detian Li</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>xiuxia Wang, doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital for Reproductive Medicine Affiliated to Shandong University</name>
      <address>
        <city>Jinan</city>
        <state>Shandong</state>
        <zip>250000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Juanjuan Lu</last_name>
      <phone>+8615169008721</phone>
      <email>juanlu2010@163.com</email>
    </contact>
    <investigator>
      <last_name>Junhao Yan, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shandong Provincial Hospital</name>
      <address>
        <city>Jinan</city>
        <state>Shandong</state>
        <zip>250000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fajuan Chen</last_name>
      <phone>+8613187057355</phone>
      <email>chengfajuan2009@163.com</email>
    </contact>
    <investigator>
      <last_name>Rong Wang, doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shanghai Changzheng Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>yiyi Ma, doctor</last_name>
      <phone>+8613661679863</phone>
      <email>dukemm@126.com</email>
    </contact>
    <investigator>
      <last_name>shengqiang Yu, doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>ningxia Sun, doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shanxi Provincial People's Hospital</name>
      <address>
        <city>Taiyuan</city>
        <state>Shanxi</state>
        <zip>030000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yankun Luo</last_name>
      <phone>+8618734195439</phone>
      <email>luoyk2012@163.com</email>
    </contact>
    <investigator>
      <last_name>Rongshan Li</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tang-Du Hospital</name>
      <address>
        <city>Xi'an</city>
        <state>Shanxi</state>
        <zip>710000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>zhanting Li</last_name>
      <phone>+8613572503218</phone>
    </contact>
    <contact_backup>
      <last_name>jie Zhang</last_name>
      <phone>+8618681853253</phone>
    </contact_backup>
    <investigator>
      <last_name>jifeng Sun, Master</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>xiaohong Wang, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shanxi Provincial People's Hospital</name>
      <address>
        <city>Chengdu</city>
        <state>Sichuan</state>
        <zip>610000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Lisha Yao</last_name>
      <phone>+8613880465744</phone>
      <email>65473059@qq.com</email>
    </contact>
    <investigator>
      <last_name>Li Wang</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Qun Lv</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>West China Hospital of Sichuan University</name>
      <address>
        <city>Chengdu</city>
        <state>Sichuan</state>
        <zip>610000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Liang Ma</last_name>
      <phone>+8618981933920</phone>
      <email>2992029730@qq.com</email>
    </contact>
    <investigator>
      <last_name>Ping Fu</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>West China Second University Hospital</name>
      <address>
        <city>Chengdu</city>
        <state>Sichuan</state>
        <zip>610000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Shan Luo</last_name>
      <phone>+8613350089826</phone>
      <email>luoshan74@126.com</email>
    </contact>
    <investigator>
      <last_name>Shangwei Li</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sir Run Run Shaw Hospital of Zhejiang University</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang</state>
        <zip>310000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiaona Lin</last_name>
      <phone>+8613588706863</phone>
      <email>linna73@263.com</email>
    </contact>
    <investigator>
      <last_name>Songying Zhang</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hua Li</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>December 2018</verification_date>
  <study_first_submitted>October 20, 2016</study_first_submitted>
  <study_first_submitted_qc>October 26, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 28, 2016</study_first_posted>
  <last_update_submitted>December 15, 2018</last_update_submitted>
  <last_update_submitted_qc>December 15, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">December 19, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Shanghai Changzheng Hospital</investigator_affiliation>
    <investigator_full_name>Changlin Mei</investigator_full_name>
    <investigator_title>Professor, Director of kidney Institute</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthrogryposis</mesh_term>
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Polycystic Kidney Diseases</mesh_term>
    <mesh_term>Polycystic Kidney, Autosomal Dominant</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

